Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 206, Issue 1, Pages 35-46Publisher
WILEY
DOI: 10.1002/jcp.20425
Keywords
-
Categories
Funding
- NCI NIH HHS [R01CA095518-01] Funding Source: Medline
- NINDS NIH HHS [P01 NS36466-06] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA095518] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS036466] Funding Source: NIH RePORTER
Ask authors/readers for more resources
)C polyomavirus (JCV), which infects 90% of the human population, is detectable in human tumors. Its early protein, JCVT-antigen, transforms cells in vitro and is tumorigenic in experimental animals. Although T-antigen-mediated transformation involves genetic alterations of the affected cells, the mechanism underlying this genomic instability is not known. We show that JCV T-antigen inhibits homologous recombination DNA repair(HRR), which results in an accumulation of mutations. T-antigen does not operate directly but utilizes a cytosolic molecule, insulin receptor substrate 1 (IRS-1). Following T-antigen-mediated nuclear translocation, IRS-1 binds Rad51 at the site of damaged DNA. This T-antigen-mediated inhibition of HRR does not function in cells lacking IRS-1, and can be reproduced in the absence of T-antigen by IRS-1 with artificial nuclear localization signal. Our observations define anew mechanism by which viral protein utilizes cytosolic molecule to inhibit faithful DNA repair, and suggest how polyomaviruses could compromise stability of the genome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available